Armistice Capital’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Armistice Capital’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,856,000	Closed	-$5.49M	–	113
2018 Q3	$5.49M	Hold	1,856,000	–	–	0.45%	56
2018 Q2	$6.83M	Hold	1,856,000	–	–	0.59%	55
2018 Q1	$6.5M	Hold	1,856,000	–	–	0.6%	50
2017 Q4	$5.79M	Hold	1,856,000	–	–	0.75%	45
2017 Q3	$13M	Buy	1,856,000 +4,000	+0.2%	+$32.1K	2.3%	24
2017 Q2	$17.1M	Hold	1,852,000	–	–	2.89%	14
2017 Q1	$19.9M	Buy	1,852,000 +432,000	+30%	+$4.41M	5.11%	5
2016 Q4	$12M	Buy	+1,420,000	New	+$12.6M	3.4%	10

Other funds holding NVLN

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

David M. Knott $264M AUM 59.23% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return